Facing Regulatory Heat, Indian Pharma Turns To Quality Solutions
Executive Summary
Against a backdrop of US FDA warnings and global regulatory convergence, the Indian pharma industry is looking to build in quality from project inception and foster an unbiased approach to quality across global markets, a conference in Mumbai hears.